Skip to main content
logo
IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
2.300
+0.010 (0.44%)
At close: Aug 28, 2026, 4:00 PM EDT
2.210
-0.090 (-3.91%)
After-hours: Aug 28, 2026, 7:44 PM EDT

IceCure Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.953.383.293.233.094.14
Revenue Growth
41.62%2.67%1.92%4.67%-25.45%6.98%
Cost of Revenue
2.522.151.841.931.641.94
Gross Profit
1.431.231.451.31.452.2
Selling, General & Admin
9.818.8910.058.69.066.04
Research & Development
8.347.437.18.279.125.88
Operating Expenses
18.1516.3217.1516.8818.1811.92
Operating Income
-16.72-15.09-15.7-15.58-16.74-9.72
Interest Expense
-0.16----0.24-0.17
Interest & Investment Income
-0.040.380.92--
Pretax Income
-16.88-15.06-15.32-14.65-16.98-9.9
Net Income
-16.88-15.06-15.32-14.65-16.98-9.9
Net Income to Common
-16.88-15.06-15.32-14.65-16.98-9.9
Net Income Growth
------
Shares Outstanding (Basic)
322211
Shares Outstanding (Diluted)
322211
Shares Change
35.73%24.97%11.48%23.29%29.66%66.67%
EPS (Basic)
-6.66-7.10-9.03-9.63-13.76-10.40
EPS (Diluted)
-6.66-7.10-9.03-9.63-13.76-10.40
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-15.94-14.61-12.63-13.03-15.18-13.14
Free Cash Flow Per Share
-6.29-6.89-7.45-8.56-12.30-13.81
Gross Margin
36.10%36.28%44.09%40.26%46.84%53.04%
Operating Margin
-423.69%-446.70%-476.94%-482.38%-542.59%-234.99%
Profit Margin
-427.67%-445.61%-465.45%-453.76%-550.34%-239.13%
Free Cash Flow Margin
-403.88%-432.38%-383.89%-403.53%-492.16%-317.50%
EBITDA
-16.44-14.8-15.36-15.25-16.49-9.6
EBITDA Margin
------231.92%
D&A For EBITDA
0.280.30.330.320.250.13
EBIT
-16.72-15.09-15.7-15.58-16.74-9.72
EBIT Margin
------234.99%
Advertising Expenses
-0.120.030.090.070.06
SEC Filings: 10-K · 10-Q